Wound healing properties of heparin-binding EGF-like growth factor (HB-EGF); pharmacotherapeutic approaches to correct cognitive impairment due to PTSD or post-COVID; obtaining recombinant analogues of bacterial toxins; development of agents for inhibiting the mitogenic activity of HB-EG; study of the immunogenic properties of proteins; development of platforms for targeted delivery of agents with antitumor activity; secondary metabolites of Streptomycetes
Wound healing properties of heparin-binding EGF-like growth factor (HB-EGF); pharmacotherapeutic approaches to correct cognitive impairment due to PTSD or post-COVID; obtaining recombinant analogues of bacterial toxins; development of agents for inhibiting the mitogenic activity of HB-EG; study of the immunogenic properties of proteins; development of platforms for targeted delivery of agents with antitumor activity; secondary metabolites of Streptomycetes